GeoVax Labs, Inc. (GOVX) CEO David A. Dodd on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/03/22
GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/03/22
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single ImmunizationGlobeNewsWire • 07/28/22
GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate UpdateGlobeNewsWire • 07/26/22
Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health EmergencyInvestorPlace • 07/25/22
GeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq RulesGlobeNewsWire • 05/25/22